Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.53
0.01 (0.12%)
At close: Aug 18, 2025, 3:59 PM
8.52
-0.12%
After-hours: Aug 18, 2025, 06:39 PM EDT
Y-mAbs Therapeutics Revenue
Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending June 30, 2025, Y-mAbs Therapeutics generated $19.52M in revenue.
Revenue (ttm)
87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
843.13K
Employees
104
Market Cap
387.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 87.69M | +3.38% |
| Dec 31, 2023 | 84.82M | +29.96% |
| Dec 31, 2022 | 65.27M | +87.03% |
| Dec 31, 2021 | 34.9M | +68.18% |
| Dec 31, 2020 | 20.75M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |